<DOC>
	<DOCNO>NCT02296047</DOCNO>
	<brief_summary>Chronic Obstructive Pulmonary Disease ( COPD ) major cause chronic morbidity , mortality disability throughout world , lead heavy social economic burden.Bronchodilators , commonly use drug COPD patient , show reduce dyspnea , improve exercise tolerance improve health status . However , conventional lung function parameter force vital capacity ( FVC ) force expiratory volume one second ( FEV1 ) frequently fail detect significant functional response bronchodilator patient chronic airflow obstruction . It necessary clinical scientific reason develop new tool objectively assess effect different treatment include bronchodilator COPD . Our previous study show Ventilation-drive coupling may sensitive accurate evaluate efficacy inhaled bronchodilator patient COPD could better reflect pathological physiological characteristic COPD . Based conclusion , present study perform use experimental method placebo self-controlled . We aimd explore value ventilation-drive couple evaluate efficacy bronchodilator COPD provide reasonable basis clinical application index .</brief_summary>
	<brief_title>Ventilation-drive Coupling Evaluate The Efficacy Inhaled Bronchodilators Patients With COPD</brief_title>
	<detailed_description>Patients randomly assign one two intervention group : 1 . Group A : Patients inhale placebo , ipratropium 80μg , salbutamol 400 μg sequence ; 2 . Group B : Patients inhale placebo , salbutamol 400μg , ipratropium 80 μg sequence . The data collect 30 minute patient inhaled placebo , 30 minute ipratropium 15 minute salbutamol .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Ipratropium</mesh_term>
	<mesh_term>Bronchodilator Agents</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>Patients age 4070 year old ; Patients pulmonary function test FEV1/FVC &lt; 70 % FEV1 % pred &lt; 50 % ; Patients clinically stable state ; Patients sign informed consent . Patients sign airway infection ; Patients acute exacerbation previous 4 week ; Patients giant bulla ( ≥3cm diameter ) ; Patients recent upper abdominal surgery ; Patients one follow disease : esophageal cancer , reflux esophagitis , severe obstructive sleep apnea ( apnea hypopnea index &gt; 15/hr ) , neuromuscular disease , significant heart failure ; Patients poor compliance .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>COPD , central drive , bronchodilator</keyword>
</DOC>